hesperetin has been researched along with Cognitive Decline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, D; Huang, K; Jing, S; Liu, Z; Su, S; Wang, Q; Wang, X; Wang, Y; Zhang, Z | 1 |
| Ali, T; Ikram, M; Jo, MG; Khan, A; Kim, MO; Muhammad, T; Rehman, SU | 1 |
2 other study(ies) available for hesperetin and Cognitive Decline
| Article | Year |
|---|---|
Hesperetin attenuates cognitive dysfunction via SIRT6/NLRP3 pathway in scopolamine-induced mice.
Topics: Animals; Antioxidants; Cognitive Dysfunction; Inflammasomes; Mice; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Scopolamine; Sirtuins | 2023 |
Hesperetin Confers Neuroprotection by Regulating Nrf2/TLR4/NF-κB Signaling in an Aβ Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Astrocytes; Biomarkers; Cell Line; Cognitive Dysfunction; Disease Models, Animal; Hesperidin; Hippocampus; Male; Memory; Memory Disorders; Mice, Inbred C57BL; Microglia; Nerve Tissue Proteins; Neuroprotection; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Signal Transduction; Synapses; Toll-Like Receptor 4 | 2019 |